Trials / Sponsors / C4 Therapeutics, Inc.
C4 Therapeutics, Inc.
Industry · 5 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multi Multiple Myeloma, Relapsed/Refractory Multiple Myeloma | Phase 2 | 2026-02-18 |
| Recruiting | A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multi Multiple Myeloma (MM) | Phase 1 | 2026-02-06 |
| Completed | A Study to Characterize the Safety, Tolerability, and Preliminary Efficacy of CFT1946 as Monotherapy and Combi Solid Tumors, Melanoma, NSCLC | Phase 1 | 2022-12-08 |
| Terminated | A Study to Assess the Safety and Tolerability of CFT8634 in Locally Advanced or Metastatic SMARCB1-Perturbed C Synovial Sarcoma, Soft Tissue Sarcoma | Phase 1 | 2022-03-25 |
| Active Not Recruiting | Study to Assess the Safety and Tolerability of CFT7455 in Relapsed/Refractory Non-Hodgkin's Lymphoma or Multip Multiple Myeloma, Lymphoma, Non-Hodgkin's | Phase 1 | 2021-04-27 |